A web of mail-order pharmacies, wholesalers and patient services groups connected to the self-styled largest Pentecostal denomination in the U.S. has been accused of defrauding pharma juggernaut Eli Lilly out of more than $200 million through a multi-year rebate scheme centered on the diabetes treatment Trulicity.

While retatrutide may have the best weight loss efficacy to date, analysts hold concerns about its tolerability profile compared with best-seller, tirzepatide.

Eli Lilly (NYSE:LLY) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5% year over year, with Mounjaro at $8.66B (+125%) and Zepbound at $4.16B (+80%). CEO David Ricks told investors “2026 is off to a strong start,

The pharmaceutical company claims four members of the Church of God in Christ fraudulently resold a discounted diabetes drug.

With construction starting soon on the massive Eli Lilly and Co. pharmaceutical plant in Upper Macungie Township, some are wondering how the hundreds of construction workers will make it to the site without snarling traffic around Fogelsville.

Eli Lilly and Company LLY traded higher on Friday after new late-stage trial data highlighted significant weight reduction in older adults using Foundayo. The drugmaker presented updated analyses from its Phase 3 ATTAIN studies during the European Congress on Obesity in Istanbul.

Deal after deal, Eli Lilly and Co. is using the fruits of its success from developing blockbuster GLP-1 medicines to prepare for its next chapter and build a bridge over a looming patent cliff.

Eli Lilly and Company (NYSE: LLY) today announced the details of presentations from across its oncology portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2 in Chicago,